GenScript Targeted LNP: Precision Delivery for Enhanced Therapeutics
The Targeted LNP service offers custom-made lipid nanoparticle formulations designed for precise therapeutic payload delivery. Enhanced with optimized antibodies and ligands, these LNPs enable targeted delivery to specific cell types, including T cells, lungs, spleen, tumors, brain, liver, and macrophages. Achieve efficient, tissue-specific delivery with GenScript’s advanced LNP technology.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
GenScript’s Targeted Lipid Nanoparticle (LNP) Service offers precision-engineered solutions for delivering therapeutic payloads to specific cell types and tissues. By integrating optimized antibodies and ligands such as CD3-Ab, 50DOTAP, COMP3, and Tri-GalNac, these LNPs enable highly efficient delivery of mRNA, saRNA, siRNA, proteins, and gene-editing tools. Designed for applications in gene therapy, oncology, immunotherapy, and metabolic diseases, this advanced platform ensures enhanced stability, bioavailability, and reduced off-target effects.
With customizable and scalable LNP formulations, GenScript’s service provides targeted delivery to T cells, lungs, spleen, tumors, brain, liver, and macrophages, improving therapeutic precision and efficacy. Whether for CRISPR-based gene editing, mRNA vaccine development, or CNS-targeted therapies, these tailored LNP solutions accelerate research and streamline the path to clinical success.
